Tag: Innosyn
-
Gamma-Valerolactone from Bio-Based Levulinic Acid as Alternative to Gamma Butyrolactone by Dr Marijn Rijkers
InnoSyn, founded on May 1st, 2017, is an R&D services spin-off from DSM to specifically focus on chemical programs to…
Latest reports
-
ENI Seeks Injunction Against Bioplastics News: Independent Journalism Under Pressure
-
Raul Gardini: The Enimont Scandal, a Controversial Death and Novamont’s Road to ENI
-
INEOS Founder Warns the UK Is on the Slide
-
Covestro CEO Attempts to Speak Italian with His Hands
-
Bio-on and Danimer Scientific: The Short Sellers Who Worked Together